NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

An optimistic view for quantifying mRNA in post-mortem human brain.

Author(s): Preece P, Virley D J, Costandi M, Coombes R, Moss S J, Mudge A W, Jazin E, Cairns N J

Publication: Brain Res Mol Brain Rees, 2003, Vol. 116, Page 7

PubMed ID: 12941456 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if the confounding variables of postmortem interval (PMI), gender, age at death, and brain pH upset the quantitative order (relative expression) of the brain transcriptome as measured by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) of seven mRNA transcripts.

Conclusion of Paper

The authors conclude that, based on their assessment of 7 genes, mRNA degradation associated with brain pH, PMI, gender, or age at death is not random, and quantitative order is preserved within an individual although absolute levels may display robust differences between individuals.

Studies

  1. Study Purpose

    The purpose of this study was to evaluate mRNA levels of beta-actin, GAPDH, cyclophilin, MAP2, NSE, APP 770, and GFAP in postmortem brain, and to investigate whether mRNA levels were influenced by patient age, gender, or diagnosis, PMI, or brain pH.

    Summary of Findings:

    While relative mRNA expression was highly variable between individuals (by 1000-fold), relative expression of different transcripts within an individual were highly correlated. Thus, the quantitative order within an individual was preserved for both genders and diagnoses examined. The authors conclude that, based on their assessment of 7 genes, mRNA degradation associated with brain pH, PMI, gender, or age at death is not random, and quantitative order is preserved within an individual although absolute levels may display robust differences between individuals.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Alzheimer's Disease
    • Autopsy
    • Not specified
    Platform:
    AnalyteTechnology Platform
    RNA Electrophoresis
    RNA Real-time qRT-PCR
    RNA Spectrophotometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Patient age 41 - 91 years
    Preaquisition Patient gender Female
    Male
    Biospecimen Aliquots and Components pH Brain pH 5.8 - 7.2
    Preaquisition Postmortem interval 4 - 117 h
    Preaquisition Diagnosis/ patient condition No diagnosis of Alzheimer's disease
    Alzheimer's disease

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...